The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dolutegravir Sodium Market Research Report 2025
Synopsis
The global Dolutegravir Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dolutegravir Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dolutegravir Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dolutegravir Sodium include ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dolutegravir Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir Sodium.
Report Scope
The Dolutegravir Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dolutegravir Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ViiV Healthcare UK
Emcure Pharmaceuticals
Aurobindo Pharma
LAURUS Labs
Mylan
Adcock Ingram Limited
Ranbaxy Pharmaceuticals
Cipla
Segment by Type
Bottled Packaging
Film Coated Packaging
Segment by Application
AIDS Adult Patients
AIDS Children over 12 Years Old
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dolutegravir Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dolutegravir Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Dolutegravir Sodium market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Dolutegravir Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dolutegravir Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dolutegravir Sodium include ViiV Healthcare UK, Emcure Pharmaceuticals, Aurobindo Pharma, LAURUS Labs, Mylan, Adcock Ingram Limited, Ranbaxy Pharmaceuticals and Cipla, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Dolutegravir Sodium, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir Sodium.
Report Scope
The Dolutegravir Sodium market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dolutegravir Sodium market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir Sodium manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ViiV Healthcare UK
Emcure Pharmaceuticals
Aurobindo Pharma
LAURUS Labs
Mylan
Adcock Ingram Limited
Ranbaxy Pharmaceuticals
Cipla
Segment by Type
Bottled Packaging
Film Coated Packaging
Segment by Application
AIDS Adult Patients
AIDS Children over 12 Years Old
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Dolutegravir Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Dolutegravir Sodium in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Dolutegravir Sodium Market Overview
1.1 Product Overview and Scope of Dolutegravir Sodium
1.2 Dolutegravir Sodium Segment by Type
1.2.1 Global Dolutegravir Sodium Market Value Comparison by Type (2024-2030)
1.2.2 Bottled Packaging
1.2.3 Film Coated Packaging
1.3 Dolutegravir Sodium Segment by Application
1.3.1 Global Dolutegravir Sodium Market Value by Application: (2024-2030)
1.3.2 AIDS Adult Patients
1.3.3 AIDS Children over 12 Years Old
1.4 Global Dolutegravir Sodium Market Size Estimates and Forecasts
1.4.1 Global Dolutegravir Sodium Revenue 2019-2030
1.4.2 Global Dolutegravir Sodium Sales 2019-2030
1.4.3 Global Dolutegravir Sodium Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Dolutegravir Sodium Market Competition by Manufacturers
2.1 Global Dolutegravir Sodium Sales Market Share by Manufacturers (2019-2024)
2.2 Global Dolutegravir Sodium Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Dolutegravir Sodium Average Price by Manufacturers (2019-2024)
2.4 Global Dolutegravir Sodium Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Dolutegravir Sodium, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dolutegravir Sodium, Product Type & Application
2.7 Dolutegravir Sodium Market Competitive Situation and Trends
2.7.1 Dolutegravir Sodium Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dolutegravir Sodium Players Market Share by Revenue
2.7.3 Global Dolutegravir Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dolutegravir Sodium Retrospective Market Scenario by Region
3.1 Global Dolutegravir Sodium Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Dolutegravir Sodium Global Dolutegravir Sodium Sales by Region: 2019-2030
3.2.1 Global Dolutegravir Sodium Sales by Region: 2019-2024
3.2.2 Global Dolutegravir Sodium Sales by Region: 2025-2030
3.3 Global Dolutegravir Sodium Global Dolutegravir Sodium Revenue by Region: 2019-2030
3.3.1 Global Dolutegravir Sodium Revenue by Region: 2019-2024
3.3.2 Global Dolutegravir Sodium Revenue by Region: 2025-2030
3.4 North America Dolutegravir Sodium Market Facts & Figures by Country
3.4.1 North America Dolutegravir Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Dolutegravir Sodium Sales by Country (2019-2030)
3.4.3 North America Dolutegravir Sodium Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dolutegravir Sodium Market Facts & Figures by Country
3.5.1 Europe Dolutegravir Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Dolutegravir Sodium Sales by Country (2019-2030)
3.5.3 Europe Dolutegravir Sodium Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dolutegravir Sodium Market Facts & Figures by Country
3.6.1 Asia Pacific Dolutegravir Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Dolutegravir Sodium Sales by Country (2019-2030)
3.6.3 Asia Pacific Dolutegravir Sodium Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dolutegravir Sodium Market Facts & Figures by Country
3.7.1 Latin America Dolutegravir Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Dolutegravir Sodium Sales by Country (2019-2030)
3.7.3 Latin America Dolutegravir Sodium Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dolutegravir Sodium Market Facts & Figures by Country
3.8.1 Middle East and Africa Dolutegravir Sodium Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Dolutegravir Sodium Sales by Country (2019-2030)
3.8.3 Middle East and Africa Dolutegravir Sodium Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Dolutegravir Sodium Sales by Type (2019-2030)
4.1.1 Global Dolutegravir Sodium Sales by Type (2019-2024)
4.1.2 Global Dolutegravir Sodium Sales by Type (2025-2030)
4.1.3 Global Dolutegravir Sodium Sales Market Share by Type (2019-2030)
4.2 Global Dolutegravir Sodium Revenue by Type (2019-2030)
4.2.1 Global Dolutegravir Sodium Revenue by Type (2019-2024)
4.2.2 Global Dolutegravir Sodium Revenue by Type (2025-2030)
4.2.3 Global Dolutegravir Sodium Revenue Market Share by Type (2019-2030)
4.3 Global Dolutegravir Sodium Price by Type (2019-2030)
5 Segment by Application
5.1 Global Dolutegravir Sodium Sales by Application (2019-2030)
5.1.1 Global Dolutegravir Sodium Sales by Application (2019-2024)
5.1.2 Global Dolutegravir Sodium Sales by Application (2025-2030)
5.1.3 Global Dolutegravir Sodium Sales Market Share by Application (2019-2030)
5.2 Global Dolutegravir Sodium Revenue by Application (2019-2030)
5.2.1 Global Dolutegravir Sodium Revenue by Application (2019-2024)
5.2.2 Global Dolutegravir Sodium Revenue by Application (2025-2030)
5.2.3 Global Dolutegravir Sodium Revenue Market Share by Application (2019-2030)
5.3 Global Dolutegravir Sodium Price by Application (2019-2030)
6 Key Companies Profiled
6.1 ViiV Healthcare UK
6.1.1 ViiV Healthcare UK Corporation Information
6.1.2 ViiV Healthcare UK Description and Business Overview
6.1.3 ViiV Healthcare UK Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.1.4 ViiV Healthcare UK Dolutegravir Sodium Product Portfolio
6.1.5 ViiV Healthcare UK Recent Developments/Updates
6.2 Emcure Pharmaceuticals
6.2.1 Emcure Pharmaceuticals Corporation Information
6.2.2 Emcure Pharmaceuticals Description and Business Overview
6.2.3 Emcure Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Emcure Pharmaceuticals Dolutegravir Sodium Product Portfolio
6.2.5 Emcure Pharmaceuticals Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Aurobindo Pharma Dolutegravir Sodium Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 LAURUS Labs
6.4.1 LAURUS Labs Corporation Information
6.4.2 LAURUS Labs Description and Business Overview
6.4.3 LAURUS Labs Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LAURUS Labs Dolutegravir Sodium Product Portfolio
6.4.5 LAURUS Labs Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Dolutegravir Sodium Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Adcock Ingram Limited
6.6.1 Adcock Ingram Limited Corporation Information
6.6.2 Adcock Ingram Limited Description and Business Overview
6.6.3 Adcock Ingram Limited Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Adcock Ingram Limited Dolutegravir Sodium Product Portfolio
6.6.5 Adcock Ingram Limited Recent Developments/Updates
6.7 Ranbaxy Pharmaceuticals
6.6.1 Ranbaxy Pharmaceuticals Corporation Information
6.6.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.6.3 Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ranbaxy Pharmaceuticals Dolutegravir Sodium Product Portfolio
6.7.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.8 Cipla
6.8.1 Cipla Corporation Information
6.8.2 Cipla Description and Business Overview
6.8.3 Cipla Dolutegravir Sodium Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cipla Dolutegravir Sodium Product Portfolio
6.8.5 Cipla Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dolutegravir Sodium Industry Chain Analysis
7.2 Dolutegravir Sodium Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dolutegravir Sodium Production Mode & Process
7.4 Dolutegravir Sodium Sales and Marketing
7.4.1 Dolutegravir Sodium Sales Channels
7.4.2 Dolutegravir Sodium Distributors
7.5 Dolutegravir Sodium Customers
8 Dolutegravir Sodium Market Dynamics
8.1 Dolutegravir Sodium Industry Trends
8.2 Dolutegravir Sodium Market Drivers
8.3 Dolutegravir Sodium Market Challenges
8.4 Dolutegravir Sodium Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dolutegravir Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Dolutegravir Sodium Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Dolutegravir Sodium Market Competitive Situation by Manufacturers in 2023
Table 4. Global Dolutegravir Sodium Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Dolutegravir Sodium Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Dolutegravir Sodium Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Dolutegravir Sodium Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Dolutegravir Sodium Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Dolutegravir Sodium, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Dolutegravir Sodium, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Dolutegravir Sodium, Product Type & Application
Table 12. Global Key Manufacturers of Dolutegravir Sodium, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Dolutegravir Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Dolutegravir Sodium as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Dolutegravir Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Dolutegravir Sodium Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Dolutegravir Sodium Sales Market Share by Region (2019-2024)
Table 19. Global Dolutegravir Sodium Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Dolutegravir Sodium Sales Market Share by Region (2025-2030)
Table 21. Global Dolutegravir Sodium Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Dolutegravir Sodium Revenue Market Share by Region (2019-2024)
Table 23. Global Dolutegravir Sodium Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Dolutegravir Sodium Revenue Market Share by Region (2025-2030)
Table 25. North America Dolutegravir Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Dolutegravir Sodium Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Dolutegravir Sodium Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Dolutegravir Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Dolutegravir Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Dolutegravir Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Dolutegravir Sodium Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Dolutegravir Sodium Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Dolutegravir Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Dolutegravir Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Dolutegravir Sodium Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Dolutegravir Sodium Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Dolutegravir Sodium Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Dolutegravir Sodium Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Dolutegravir Sodium Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Dolutegravir Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Dolutegravir Sodium Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Dolutegravir Sodium Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Dolutegravir Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Dolutegravir Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Dolutegravir Sodium Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Dolutegravir Sodium Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Dolutegravir Sodium Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Dolutegravir Sodium Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Dolutegravir Sodium Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Dolutegravir Sodium Sales (K Pcs) by Type (2019-2024)
Table 51. Global Dolutegravir Sodium Sales (K Pcs) by Type (2025-2030)
Table 52. Global Dolutegravir Sodium Sales Market Share by Type (2019-2024)
Table 53. Global Dolutegravir Sodium Sales Market Share by Type (2025-2030)
Table 54. Global Dolutegravir Sodium Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Dolutegravir Sodium Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Dolutegravir Sodium Revenue Market Share by Type (2019-2024)
Table 57. Global Dolutegravir Sodium Revenue Market Share by Type (2025-2030)
Table 58. Global Dolutegravir Sodium Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Dolutegravir Sodium Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Dolutegravir Sodium Sales (K Pcs) by Application (2019-2024)
Table 61. Global Dolutegravir Sodium Sales (K Pcs) by Application (2025-2030)
Table 62. Global Dolutegravir Sodium Sales Market Share by Application (2019-2024)
Table 63. Global Dolutegravir Sodium Sales Market Share by Application (2025-2030)
Table 64. Global Dolutegravir Sodium Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Dolutegravir Sodium Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Dolutegravir Sodium Revenue Market Share by Application (2019-2024)
Table 67. Global Dolutegravir Sodium Revenue Market Share by Application (2025-2030)
Table 68. Global Dolutegravir Sodium Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Dolutegravir Sodium Price (USD/Pcs) by Application (2025-2030)
Table 70. ViiV Healthcare UK Corporation Information
Table 71. ViiV Healthcare UK Description and Business Overview
Table 72. ViiV Healthcare UK Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. ViiV Healthcare UK Dolutegravir Sodium Product
Table 74. ViiV Healthcare UK Recent Developments/Updates
Table 75. Emcure Pharmaceuticals Corporation Information
Table 76. Emcure Pharmaceuticals Description and Business Overview
Table 77. Emcure Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. Emcure Pharmaceuticals Dolutegravir Sodium Product
Table 79. Emcure Pharmaceuticals Recent Developments/Updates
Table 80. Aurobindo Pharma Corporation Information
Table 81. Aurobindo Pharma Description and Business Overview
Table 82. Aurobindo Pharma Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Aurobindo Pharma Dolutegravir Sodium Product
Table 84. Aurobindo Pharma Recent Developments/Updates
Table 85. LAURUS Labs Corporation Information
Table 86. LAURUS Labs Description and Business Overview
Table 87. LAURUS Labs Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. LAURUS Labs Dolutegravir Sodium Product
Table 89. LAURUS Labs Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Mylan Dolutegravir Sodium Product
Table 94. Mylan Recent Developments/Updates
Table 95. Adcock Ingram Limited Corporation Information
Table 96. Adcock Ingram Limited Description and Business Overview
Table 97. Adcock Ingram Limited Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Adcock Ingram Limited Dolutegravir Sodium Product
Table 99. Adcock Ingram Limited Recent Developments/Updates
Table 100. Ranbaxy Pharmaceuticals Corporation Information
Table 101. Ranbaxy Pharmaceuticals Description and Business Overview
Table 102. Ranbaxy Pharmaceuticals Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Ranbaxy Pharmaceuticals Dolutegravir Sodium Product
Table 104. Ranbaxy Pharmaceuticals Recent Developments/Updates
Table 105. Cipla Corporation Information
Table 106. Cipla Description and Business Overview
Table 107. Cipla Dolutegravir Sodium Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. Cipla Dolutegravir Sodium Product
Table 109. Cipla Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Dolutegravir Sodium Distributors List
Table 113. Dolutegravir Sodium Customers List
Table 114. Dolutegravir Sodium Market Trends
Table 115. Dolutegravir Sodium Market Drivers
Table 116. Dolutegravir Sodium Market Challenges
Table 117. Dolutegravir Sodium Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dolutegravir Sodium
Figure 2. Global Dolutegravir Sodium Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Dolutegravir Sodium Market Share by Type in 2023 & 2030
Figure 4. Bottled Packaging Product Picture
Figure 5. Film Coated Packaging Product Picture
Figure 6. Global Dolutegravir Sodium Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Dolutegravir Sodium Market Share by Application in 2023 & 2030
Figure 8. AIDS Adult Patients
Figure 9. AIDS Children over 12 Years Old
Figure 10. Global Dolutegravir Sodium Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Dolutegravir Sodium Market Size (2019-2030) & (US$ Million)
Figure 12. Global Dolutegravir Sodium Sales (2019-2030) & (K Pcs)
Figure 13. Global Dolutegravir Sodium Average Price (USD/Pcs) & (2019-2030)
Figure 14. Dolutegravir Sodium Report Years Considered
Figure 15. Dolutegravir Sodium Sales Share by Manufacturers in 2023
Figure 16. Global Dolutegravir Sodium Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Dolutegravir Sodium Players: Market Share by Revenue in 2023
Figure 18. Dolutegravir Sodium Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Dolutegravir Sodium Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Dolutegravir Sodium Sales Market Share by Country (2019-2030)
Figure 21. North America Dolutegravir Sodium Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Dolutegravir Sodium Sales Market Share by Country (2019-2030)
Figure 25. Europe Dolutegravir Sodium Revenue Market Share by Country (2019-2030)
Figure 26. Germany Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Dolutegravir Sodium Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Dolutegravir Sodium Revenue Market Share by Region (2019-2030)
Figure 33. China Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Dolutegravir Sodium Sales Market Share by Country (2019-2030)
Figure 44. Latin America Dolutegravir Sodium Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Dolutegravir Sodium Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Dolutegravir Sodium Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. U.A.E Dolutegravir Sodium Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Dolutegravir Sodium by Type (2019-2030)
Figure 54. Global Revenue Market Share of Dolutegravir Sodium by Type (2019-2030)
Figure 55. Global Dolutegravir Sodium Price (USD/Pcs) by Type (2019-2030)
Figure 56. Global Sales Market Share of Dolutegravir Sodium by Application (2019-2030)
Figure 57. Global Revenue Market Share of Dolutegravir Sodium by Application (2019-2030)
Figure 58. Global Dolutegravir Sodium Price (USD/Pcs) by Application (2019-2030)
Figure 59. Dolutegravir Sodium Value Chain
Figure 60. Dolutegravir Sodium Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
